Clovis Oncology, Inc

CLVS NASDAQ

CryptoFundManager

CLVS Clovis Oncology is sitting at a strong support area ready for a bounce. My Price target is the 10usd resistance level On 5/5/2021 HC Wainwright brokerage Lowered the Price Target for CLVS Clovis Oncology to Buy Rating from $13.00 to$12.00

PennyStocks101

Took the chart back out to March of last year to do a little fib retracement. Wouldn't you know, CLVS has been channel bound for a minute between the 618 and 786 fib lines with pretty clear support and resistance levels at each. Since it retraced back to the 786 again and is holding (for now), volume is likely going to be the "friend" or "foe" depending on how...

moveforward01

owning shares down here, looking to accumulate into dips going forward + covered calls when I see volume ramp. Debating puts for now as I think this latest move could be a head fake. Eying some near term gap fills. No SLs here for me, very patient. Thinking it'll catch a bid on the back of flows into bitech ETFs this summer/fall coupled with good PR.

KQ5

$CLVS short squeeze path

TradeandGrow

Due the technical analysis it seems the EMA 100/200 is finally curling and the downtrend could probably be over. The MACD was really quite in the last time and we should see some action again soon. The entry point is well, we could see another drop but after we should finally climb again in higher areas. My price targets and stop loss is mentioned in the...

opcondour

CLVS has been in a sideways consolidation since April with strong support at $5 and some resistance above $7.00 looks bullish with Catalyst into September Rubraca results. Accumulating below $6 with full position on a break and restest of $7. Of note short interest north of 25%

bosco

NASDAQ:CLVS CLVS may be ready to advance from the 200 MA towards the upside. Near term target price is around 7.

wedgietime

Money cometh. Money goeth.

AhmadAidarous

Bullish View foe CLVS

PlanTradePlanMM

Weekly In bottom wedge SMA20/40 as support OBV> OBV40 Entry 5.9 Stop 4.5 Target 15 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an account. I am not a PRO trader. I trade option to test my trading plan with small cost.

torekx

As in the image. A lot of volume on the current multi-monthly bottom. In my opinion, someone is buying heavy and it's just a matter of time to reverse the trend. MACD-price divergence also looks bullish.

OptionsPortal

Could CLVS be the next in line for a huge short squeeze? Meme stocks have recently become all the rage so anything is possible and the most heavily shorted stocks are the targets. Short Float is currently sitting at around 30% and volume has been increasing over the past months. If it were to play out, the risk to reward for the trade with a target of $90 would...

moveforward01

bullish to $12.97 and beyond that point I turn into a pig tagged for slaughter...we'll see; if RSI and accum remain strong, I'm still onboard 🤙🏽

moveforward01

she a painted a green doji after a midday bloodbath. Accumulated a couple hundred shares into this weakness today, if we see more weakness tomorrow, I'll scoop up some long dated out of the monies. ~$9 and you get a modest gap fill, higher w/a volume push beyond that resistance and it could get pumped to gawd knows where. My thesis is if it breaks out it'll do it...

cmca17

CLVS short squeeze just beginning.

tizianob

According to the indicator at the base of the advisor Marketmiracle the CLVS stock is accumulating capitals and is ready for an explosion. Clovis Oncology is one of the best-selling low-cost titles but produces a drug capable of improving the lives of cancer patients worldwide. Clearly the money devoted to biotech and pharmaceutical companies during the covid...

suomenlinna

This not financial advice.

tizianob

I've no doubt... next week will be explosive for CLVS I'm not a finalcial advisor and this is just my opinion based on some indicators.